AMP 2026 exhibitors
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
185 organizations exhibit at AMP 2026 — 173 diagnostics, instrument, software and pharmaceutical companies, 8 clinical laboratories, 2 academic medical centres, children's hospitals and universities and 2 agencies, societies and non-profits. 64 of them also present on the scientific program, with 112 presentations between them. Most represented: PacBio (3 on the program), Promega (3 on the program), Roche Diagnostics (3 on the program). 70 of them have their own page in this guide. As of Sep 25, 2026.
Program track
Top represented
Showing 1–30 of 185 organizations
| Organization | AMP 2026 Attendance |
|---|---|
PacBio Menlo Park, CA | |
Sequencing technologies combining long reads with high accuracy for genomes, transcriptomes and epigenomes. | Booth Exhibiting at Booth 1018 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Fri, Nov 13 12:00pm–12:30pm Accelerating Clinical Genomics with HiFi Sequencing: Targeted and Rapid Whole-Genome Workflows Long-read workflows for repeat expansion disorders and other hard genomic regions, plus a faster whole-genome protocol. |
Promega Madison, WI | |
Nucleic acid extraction, PCR reagents and custom or OEM manufacturing for clinical laboratories, with technical support. | Booth Exhibiting at Booth 610 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Workshop Wed, Nov 11 9:00am–9:50am OncoMate® MSI Dx as a Companion Diagnostic for Microsatellite Instability: Clinical Context, Validation, and Performance Microsatellite instability testing as a companion diagnostic for checkpoint inhibitor eligibility, with accuracy and concordance data. |
Roche Diagnostics Indianapolis, IN | |
Clinical diagnostics, life science research, digital PCR and next-generation sequencing systems and assays for laboratories. | Booth Exhibiting at Booth 700 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Complete Lyo-Ready Workflow: From Sample Preparation to Amplification A shelf-stable reagent set spanning sample prep, reverse transcription and amplification for assays built without cold-chain storage. Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. Workshop Wed, Nov 11 1:00pm–1:50pm Versatile Whole-exome Sequencing Enables End-to-end Phenotype-driven DNA-variant identification or RNA-fusion detection Phenotype-driven exome workflows for germline variant discovery, plus two RNA-sequencing routes to fusions. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. |
Bio-Rad Laboratories Hercules, CA | |
Products for life science research and clinical diagnostics, including droplet digital PCR, real-time PCR and molecular quality controls and standards. | Booth Exhibiting at Booth 537, MR16 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700™ ddPCR™ System Multiplexed droplet digital PCR assays that pull more oncology biomarker data from limited samples, including residual disease monitoring. |
Cellecta Mountain View, CA | |
Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR. | Booth Exhibiting at Booth 2205 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma. Workshop Sat, Nov 14 9:30am–10:00am Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates. |
Countable Labs Palo Alto, CA | |
Countable PCR uses single-molecule isolation for fusion and rare variant detection, minimal residual disease monitoring and absolute ctDNA quantification. | Booth Exhibiting at Booth 943 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. |
Covaris Woburn, MA | |
Sample preparation for multiomics research and clinical labs, using focused-acoustics instruments, consumables, reagents and kits. A PerkinElmer company. | Booth Exhibiting at Booth 2409 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm Optimizing FFPE tissue stewardship: Covaris truXTRAC automated workflow delivers superior performance for tumor-informed Haystack® MRD assay Getting more DNA and RNA from each FFPE slide so scarce tumour tissue stretches across several sequencing assays. Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. |
Guardant Health Palo Alto, CA | |
Precision oncology company offering blood and tissue tests, real-world data and AI analytics for cancer care. | Booth Exhibiting at Booth 1043 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
Natera San Carlos, CA | |
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring. | Booth Exhibiting at Booth 445 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing. |
Nationwide Children's Hospital Columbus, OH | |
Pediatric academic medical center in Columbus, Ohio; its genomic medicine institute runs clinical and research sequencing. | Booth Exhibiting at Booth 2008 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Poster Thu, Nov 12 2:45pm–3:00pm Workshop Thu, Nov 12 4:25pm–4:55pm Want to get involved with AMP? Volunteering pathways in the professional society, from short time-limited tasks through committee membership and leadership roles. |
SOPHiA GENETICS Saint-Sulpice, Switzerland | |
SOPHiA AI platform for analyzing genomic and radiomic data, used by healthcare institutions for clinical research. | Booth Exhibiting at Booth 715 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am One Integrated Workflow from Tissue to Liquid Biopsy: Real-World Insights on MSK-IMPACT® Flex and MSK-ACCESS® powered with SOPHiA DDM™ One platform covering tissue and blood comprehensive genomic profiling, with real-world results from a cancer centre. Workshop Wed, Nov 11 9:00am–9:50am Scaling Decentralized Pan-Cancer Liquid Biospy: Multicentric Validation of MSK-ACCESS® powered with SOPHiA DDM™ Multi-site validation of a pan-cancer blood test, covering variants, copy number, fusions, MSI and circulating tumour DNA. |
Illumina San Diego, CA | |
Sequencing instruments and reagents for clinical, research and applied markets, spanning oncology, reproductive health and genetic disease. | Booth Exhibiting at Booth 727, MR1, MR2 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner Workshop Wed, Nov 11 11:00am–11:50am Expanding Precision Oncology: Practical Strategies for Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling Tissue and liquid biopsy genomic profiling run side by side, covering test algorithms, lab operations and case examples. Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Workshop Fri, Nov 13 3:00pm–3:30pm Comprehensive Tumor Profiling Beyond Panels: Methylation-Aware WGS Enabled by Advanced Informatics Whole-genome sequencing with methylation and fragmentomic analysis moves tumor profiling beyond targeted panels, using DRAGEN informatics. |
Thermo Fisher Scientific Waltham, MA | |
Research and diagnostic solutions for molecular laboratories: next-generation sequencing, real-time PCR, Sanger sequencing and bioinformatics across oncology, pharmacogenomics and infectious disease. | Booth Exhibiting at Booth 709, MR10, MR4 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop Wed, Nov 11 11:00am–11:50am Novel NGS Applications in Oncology Research: TCR Sequencing and Methylation-Based ctDNA Analysis T-cell receptor sequencing and methylation-based circulating tumor DNA analysis open new angles on immune response and tumor signals. Workshop Wed, Nov 11 1:00pm–1:50pm Implementing Clinical Pharmacogenomics: Practical Lessons from Assay to Actionable Care Getting pharmacogenomic testing into routine care: test selection, lab workflow, reporting, reimbursement and health record integration. Workshop Wed, Nov 11 2:00pm–2:50pm Advancing precision oncology research: Integrating pharmacogenomics and genomic profiling using a single, rapid NGS workflow on the Genexus System Folding DPYD pharmacogenomic content into tumour sequencing so one run covers both drug-response and tumour profiling. Workshop Wed, Nov 11 3:00pm–3:50pm Bridging the Clinical Gap: Retrospective Microsatellite Instability Testing to Inform Complex Biospecimen Cohort Generation Microsatellite instability testing across hundreds of banked tumor specimens builds characterized cohorts for immunotherapy research. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. Workshop Wed, Nov 11 9:00am–9:50am From Assay to Answer: Genomic Technologies and Multiplex Workflow Solutions for Infectious Disease Research Pathogen detection by qPCR and digital PCR, with assay design and multiplexing choices for adding targets within one reaction. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance. |
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
GenomOncology Cleveland, OH | |
Clinical decision support for molecular pathology and oncology: sequencer integration, variant annotation, clinical trial matching and customizable reporting. | Booth Exhibiting at Booth 2204, MR11 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Built for the Lab You Actually Run: A Deep Dive Into Configurable Tertiary Analysis Configurable variant interpretation software judged against real lab deployments, from curation and liquid biopsy to structured reporting. Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Thu, Nov 12 6:15pm–6:45pm One Platform, Every Lab: Comprehensive Tertiary Analysis that Adapts to How You Test A single platform handles somatic and germline panels together, adapting to each lab's classification rules and reporting standards. |
LGC Teddington, UK | |
Quality controls, reference materials, diagnostic panels, NGS controls and proficiency testing for clinical laboratories, through its SeraCare clinical diagnostics business. | Booth Exhibiting at Booth 1804, MR13 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm You’re So Naïve: Best Practices and Gold-Standard Reference Material for Tumor-Agnostic MRD Testing Tumor-agnostic residual disease assays face validation hurdles, weighed against tumor-informed testing alongside reference materials. |
QIAGEN Venlo, Netherlands | |
Sample preparation kits, assay technologies and bioinformatics for extracting DNA and RNA insights in research, clinical and applied testing laboratories. | Booth Exhibiting at Booth 529, MR18 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Advancing Cell-Free Nucleic Acid Testing: Integrated Workflows for Prenatal and Oncology Applications Cell-free DNA and RNA workflows for prenatal screening and oncology, including why DNA-only sequencing misses actionable fusions. Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
Agena Bioscience San Diego, CA | |
MassARRAY platform for targeted genomic analysis — mutation profiling, liquid biopsy and pharmacogenetics for research laboratories. | Booth Exhibiting at Booth 629 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Talk Tue, Nov 10 9:00am–4:30pm Workshop Wed, Nov 11 11:00am–11:50am NAT2 Pharmacogenomics: Applying CPIC Guidelines with CDC GeT-RM Reference Materials NAT2 acetylator genotyping: applying dosing guidelines and using CDC reference materials to validate the assay. Workshop Wed, Nov 11 12:00pm–12:50pm DPYD - From Guidelines to Implementation Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers. Talk Fri, Nov 13 10:15am–11:45am |
Arima Genomics Carlsbad, CA | |
Cancer diagnostics from whole-genome sequence and structure; runs the CLIA-certified Aventa clinical lab and supplies research kits and informatics. | Booth Exhibiting at Booth 536 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. |
biomodal Saffron Walden, UK | |
Multiomic sequencing chemistry resolving genetic variants and DNA methylation, including 5mC and 5hmC, from a single low-input DNA, cfDNA or FFPE sample. | Booth Exhibiting at Booth 2116 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Thu, Nov 12 4:25pm–4:55pm Integrated genetic, epigenetic and fragmentomic profiling with duet supports ctDNA detection and liquid biopsy biomarker discovery One workflow reads sequence variants, methylation and fragment patterns from the same cell-free DNA, lowering the detection limit for ctDNA. |
Broad Clinical Labs Burlington, MA | |
CLIA-certified, CAP-accredited subsidiary of the Broad Institute offering multi-omic data generation and analysis for research, translational and clinical use. | Booth Exhibiting at Booth 2304 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Talk Sat, Nov 14 3:30pm–4:00pm Base-Resolution Multiomic Profiling for Rare Cancers and Beyond Machine learning on multiomic cell-free DNA classifies pediatric solid tumors such as Wilms tumor and sarcoma from limited samples. |
Cincinnati Children's Hospital Medical Center Cincinnati, OH | |
Pediatric academic medical center whose laboratories offer clinical molecular and genetic testing to outside providers. | Booth Exhibiting at Booth 2510 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Talk Sat, Nov 14 1:45pm–2:15pm AMP Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group A working-group update on making genomic variant data interoperable in electronic health records, and where standards still fall short. Talk Sat, Nov 14 2:30pm–3:00pm A Clearer View of Structural Variation: The Role of Optical Genome Mapping in Genetic Disease and Pediatric Cancer Diagnostics Optical genome mapping resolves copy number and balanced structural changes that microarrays and short-read sequencing leave cryptic. |
Clear Labs San Carlos, CA | |
Automated next-generation sequencing platform combining DNA sequencing, robotics and cloud bioinformatics for clinical and public health genomics. | Booth Exhibiting at Booth 743 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Workshop Wed, Nov 11 9:00am–9:50am Streamlined Comprehensive Genomic Profiling on Clear Dx: Automated Extraction and Library Prep on One Platform Automating extraction and library prep for a tumor profiling panel, compared with the manual workflow on clinical FFPE specimens. |
Fapon Biotech Dongguan, China | |
In vitro diagnostics supplier of reagent raw materials, reagent services and open instrument platforms for partners worldwide. | Booth Exhibiting at Booth 1905 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Full Potential of Enzymes in Molecular Diagnostics Engineered enzymes for PCR, isothermal amplification and sequencing prep, including a reverse transcriptase tuned for long-read libraries. |
Inocras San Diego, CA | |
Whole-genome sequencing and AI-driven bioinformatics for cancer and rare disease, offering clinical testing and research data integration. | Booth Exhibiting at Booth 2305 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
Intelliseq Krakow, Poland | |
iFlow cloud platform automating genomic data analysis and reporting for pharmacogenomics, germline disorders, somatic cancer and polygenic risk scores. | Booth Exhibiting at Booth 1904 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Fri, Nov 13 12:40pm–1:10pm Making Pharmacogenomics Actionable: From Variant Interpretation to Clinical Decisions Software that turns pharmacogenetic panel results into interpreted reports and prescribing guidance, extending existing commercial panels. Workshop Sat, Nov 14 12:00pm–12:30pm |
MRC Holland Amsterdam, Netherlands | |
Assays for gene copy number and methylation detection, including MLPA and digitalMLPA probemixes for hereditary disorders and tumour profiling. | Booth Exhibiting at Booth 643 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Strategies for Optimizing Nucleic Acid Extraction in Molecular Oncology Workflows: Liquid Biopsy, FFPE, and Beyond Magnetic bead extraction tuned for high-throughput oncology workflows, covering FFPE tissue and cell-free DNA from plasma. |
nRichDX Irvine, CA | |
Revolution sample prep system and kits extracting cfDNA and cfRNA from plasma, urine and other biofluids, plus CTC enrichment from blood. | Booth Exhibiting at Booth 915 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Poster Sat, Nov 14 1:15pm–1:30pm |
Oxford Nanopore Technologies Oxford, UK | |
Nanopore-based sensing technology for real-time DNA and RNA analysis across human, microbial and environmental samples, including cancer research. | Booth Exhibiting at Booth 604 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm Rapid Tumor Profiling With Real-Time Nanopore Sequencing Nanopore sequencing with adaptive sampling profiles brain tumors and leukemia, reading methylation directly for rapid tumor classification. Workshop Wed, Nov 11 1:00pm–1:50pm Enabling More Complete Rare Disease Analysis With Long-Read Sequencing Rare disease cases often hinge on repeat expansions, structural variants and methylation that long-read sequencing can resolve. Poster Thu, Nov 12 2:30pm–2:45pm |
Quest Diagnostics Secaucus, NJ | |
National clinical laboratory offering diagnostic testing, information and services to physicians, hospitals and patients. | Booth Exhibiting at Booth 2402 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–3:50pm Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement. |
Instantly find 20 buyers from AMP 2026 exhibitors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
- Exhibitors 185
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction